Francisco Morís

Francisco Morís has over 25 years of experience in the biotech industry across different roles as a manager, entrepreneur, expert consultant, visiting professor and research scientist. Experienced in both small and large companies, cross-functional team work and coordination, project management, technology transfer and business development. Innovative researcher, strong publication (h-index 34) and patent record (20 families), skilled in business, operational and strategic planning, as well as fundraising from public and private sources.

Built an oncology drug development company from scratch, launching early discovery programs, up to completion of regulatory GLP preclinical studies, alongside with CMC development for GMP manufacturing. Supervised a cross-functional group of scientists, KOLs, CROs and external consultants, teamed up with business development managers to capture external funding, successfully solicited grant awards to fund innovative R&D initiatives.

Francisco received his Ph.D. in 1994 from the University of Oviedo, supervised by Prof Vicente Gotor, and was a postdoctoral fellow in the labs of Prof. Chi-Huey Wong at The Scripps Research Institute in La Jolla (USA). Dr Morís has worked in Biotech (ThermoGen, MediChem, deCode Genetics) and Pharma Companies (Bristol-Myers Squibb) in the United States before launching and leading EntreChem SL, a spin-off company focused on oncology drug development based on synthetic biology, genetic engineering and biocatalysis. Francisco raised >10M€ in public and private funding, positioning EntreChem as the only company in the world with two hybrid natural products close to clinical trials.